Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin - PubMed

Review

Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin

Michael P Bogenschutz. Curr Drug Abuse Rev. 2013 Mar.

Abstract

Recent developments in the study of classic hallucinogens, combined with a re-appraisal of the older literature, have led to a renewal of interest in possible therapeutic applications for these drugs, notably their application in the treatment of addictions. This article will first provide a brief review of the research literature providing direct and indirect support for the possible therapeutic effects of classic hallucinogens such as psilocybin and lysergic acid diethylamide (LSD) in the treatment of addictions. Having provided a rationale for clinical investigation in this area, we discuss design issues in clinical trials using classic hallucinogens, some of which are unique to this class of drug. We then discuss the current status of this field of research and design considerations in future randomized trials.

Similar articles

• Therapeutic Applications of Classic Hallucinogens.

  Bogenschutz MP, Ross S. Bogenschutz MP, et al. Curr Top Behav Neurosci. 2018;36:361-391. doi: 10.1007/7854_2016_464. Curr Top Behav Neurosci. 2018. PMID: 28512684 Review.

• d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.

  De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G. De Gregorio D, et al. Prog Brain Res. 2018;242:69-96. doi: 10.1016/bs.pbr.2018.07.008. Epub 2018 Aug 31. Prog Brain Res. 2018. PMID: 30471683 Review.

• Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses.

  Bogenschutz MP, Pommy JM. Bogenschutz MP, et al. Drug Test Anal. 2012 Jul-Aug;4(7-8):543-55. doi: 10.1002/dta.1376. Epub 2012 Jul 4. Drug Test Anal. 2012. PMID: 22761106 Review.

• Classic hallucinogens in the treatment of addictions.

  Bogenschutz MP, Johnson MW. Bogenschutz MP, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:250-8. doi: 10.1016/j.pnpbp.2015.03.002. Epub 2015 Mar 14. Prog Neuropsychopharmacol Biol Psychiatry. 2016. PMID: 25784600 Review.

• [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].

  Majić T, Jungaberle H, Schmidt TT, Zeuch A, Hermle L, Gallinat J. Majić T, et al. Fortschr Neurol Psychiatr. 2017 Jul;85(7):383-392. doi: 10.1055/s-0043-103085. Epub 2017 Aug 2. Fortschr Neurol Psychiatr. 2017. PMID: 28768346 Review. German.

Cited by

• Structure of a Hallucinogen-Activated Gq-Coupled 5-HT_2A Serotonin Receptor.

  Kim K, Che T, Panova O, DiBerto JF, Lyu J, Krumm BE, Wacker D, Robertson MJ, Seven AB, Nichols DE, Shoichet BK, Skiniotis G, Roth BL. Kim K, et al. Cell. 2020 Sep 17;182(6):1574-1588.e19. doi: 10.1016/j.cell.2020.08.024. Cell. 2020. PMID: 32946782 Free PMC article.

• Current Perspective on the Therapeutic Preset for Substance-Assisted Psychotherapy.

  Thal SB, Bright SJ, Sharbanee JM, Wenge T, Skeffington PM. Thal SB, et al. Front Psychol. 2021 Jul 13;12:617224. doi: 10.3389/fpsyg.2021.617224. eCollection 2021. Front Psychol. 2021. PMID: 34326789 Free PMC article. Review.

• The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions.

  Nielson EM, May DG, Forcehimes AA, Bogenschutz MP. Nielson EM, et al. Front Pharmacol. 2018 Feb 21;9:132. doi: 10.3389/fphar.2018.00132. eCollection 2018. Front Pharmacol. 2018. PMID: 29515449 Free PMC article.

• Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse.

  Meinhardt MW, Güngör C, Skorodumov I, Mertens LJ, Spanagel R. Meinhardt MW, et al. Neuropsychopharmacology. 2020 Jul;45(8):1316-1322. doi: 10.1038/s41386-020-0694-z. Epub 2020 May 5. Neuropsychopharmacology. 2020. PMID: 32369828 Free PMC article.

• Effects of hallucinogenic drugs on the human heart.

  Neumann J, Dhein S, Kirchhefer U, Hofmann B, Gergs U. Neumann J, et al. Front Pharmacol. 2024 Feb 2;15:1334218. doi: 10.3389/fphar.2024.1334218. eCollection 2024. Front Pharmacol. 2024. PMID: 38370480 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Bentham Science Publishers Ltd.
  • Ingenta plc
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Medical

  • MedlinePlus Health Information